Visby Medical Raises Additional $35M; Brings Series E to Over $135M
Summary
Visby Medical, a San Jose, CA-based medical diagnostic company, expanded its Series E financing to include an additional $35m for a total of over $135m raised in the round. The additional investment was led by Lightrock, who joined existing Series E investors including John Doerr, Cedars Sinai Medical Center, ND Capital, Artiman Ventures, Pitango Venture Capital, Blue Water Life Science Advisors and J Ventures. Led by Founder and CEO Adam de la Zerda, PhD., Visby Medical is advancing patented gold standard PCR diagnostic technology in multiple therapeutic areas. The Visby Medical technology is also helping to fight the global pandemic via the Visby Medical COVID-19 Test, and its pipeline includes tests for other infectious diseases. The company is accelerating the delivery of fast and accurate, palm-sized PCR diagnostics to the point of care, and eventually for use at home.